Similar articles for PMID: 19892815

Year	Number of Results
1991	1
1992	2
1993	2
1994	3
1995	5
1996	5
1997	3
1998	5
1999	2
2000	3
2001	4
2002	8
2003	9
2004	8
2005	2
2006	7
2007	5
2008	5
2009	3
2010	9
2011	3
2012	4
2013	2
2014	4
2015	4
2016	1
2017	4
2019	2
2021	1
2022	2

1

Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings.

Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM. Salgado RA, et al. AJNR Am J Neuroradiol. 2010 Mar;31(3):565-6. doi: 10.3174/ajnr.A1889. Epub 2009 Nov 5. AJNR Am J Neuroradiol. 2010. PMID: 19892815 Free PMC article.

2

Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.

Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R. Castillo M, et al. AJNR Am J Neuroradiol. 1995 Jan;16(1):141-7. AJNR Am J Neuroradiol. 1995. PMID: 7900583 Free PMC article.

3

MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.

Willemsen MA, Van Der Graaf M, Van Der Knaap MS, Heerschap A, Van Domburg PH, Gabreëls FJ, Rotteveel JJ. Willemsen MA, et al. AJNR Am J Neuroradiol. 2004 Apr;25(4):649-57. AJNR Am J Neuroradiol. 2004. PMID: 15090362 Free PMC article.

4

Changes in neuronal metabolites in brain following subarachnoid haemorrhage evaluated by proton MR spectroscopy.

Handa Y, Kimura H, Arishima H, Ishida M, Ishii H, Kubota T. Handa Y, et al. Acta Neurochir Suppl. 2001;77:135-8. doi: 10.1007/978-3-7091-6232-3_29. Acta Neurochir Suppl. 2001. PMID: 11563272 No abstract available.

5

Neuroaxonal dystrophy: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.

Mutlu H, Sildiroglu HO, Sonmez G, Ozturk E, Kizilkaya E. Mutlu H, et al. J Neuroradiol. 2006 Jun;33(3):207-8. doi: 10.1016/s0150-9861(06)77546-0. J Neuroradiol. 2006. PMID: 16840966 No abstract available.

6

Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Poptani H, et al. AJNR Am J Neuroradiol. 1995 Sep;16(8):1593-603. AJNR Am J Neuroradiol. 1995. PMID: 7502961 Free PMC article.

7

Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome.

Eichler FS, Wang P, Wityk RJ, Beauchamp NJ Jr, Barker PB. Eichler FS, et al. AJNR Am J Neuroradiol. 2002 May;23(5):833-7. AJNR Am J Neuroradiol. 2002. PMID: 12006287 Free PMC article.

8

[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].

Szafirska M, Urbanik A, Róg T. Szafirska M, et al. Przegl Lek. 2013;70(5):328-34. Przegl Lek. 2013. PMID: 23944105 Polish.

9

Proton MRS: N-acetyl aspartate, creatine, and choline.

Maton BM, Kuzniecky RI. Maton BM, et al. Adv Neurol. 2000;83:253-9. Adv Neurol. 2000. PMID: 10999207 Review. No abstract available.

10

Neuroimaging and neurophysiology studies in carriers of cree leukoencephalopathy.

Huntsman RJ, Lemire EG, Voll CL, Wiebe S, Lowry NJ. Huntsman RJ, et al. Can J Neurol Sci. 2011 Mar;38(2):347-8. doi: 10.1017/s0317167100011586. Can J Neurol Sci. 2011. PMID: 21320845 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed